By means of heparin-affinity and glycyrrhizin (GL)-affinity column chromatographies (HPLC), a GL-binding phospholipase A2 (gbPLA2) was selectively purified from the synovial fluids of patients with rheumatoid arthritis. This purified gbPLA2 was identified as a secretory type IIA PLA2 (sPLA2-IIA) since it was crossreacted with anti-sPLA2-IIA serum. The activity of purified sPLA2-IIA was inhibited by glycyrrhetinic acid (GA) and a GA derivative (oGA) in a dose-dependent manner, but it was more sensitive to GA than GL. Furthermore, it was found that (i) purified sPLA2-IIA is phosphorylated by casein kinase II (CK-II) in vitro; (ii) this phosphorylation induces in a significant stimulation of PLA2 activity; and (iii) oGA at one-tenth the concentration of GL inhibits the CK-II-mediated stimulation of sPLA2-IIA activity. These results show that (i) sPLA2-IIA is a GL-binding protein; and (ii) CK-II mediates stimulation of its PLA2 activity in vitro.
更多
- Severe autoimmune hemolytic anemia in a patient with chronic hepatitis C
- APASL2006中文版
- PROSPECTIVE ASSESSMENT OF THE INCIDENCE OF INFECTIONS DURING PEGYLATED INTERFERO
- A Long-Term Glycyrrhizin Injection Therapy Reduces Hepatocellular Carcinogenesis
- Glycyrrhizin in Chronic Hepatitis C Patients
- Therapeutic effects of stronger neo-minophagen C at different doses on chronic
- Therapeutic effects of Stronger Neo-Minophagen C (SNMC) in patients with chronic
- Randomized clinical trial with SNMC in Chin-BE Wang-ok
- The long term efficacy of glycyrrhizin in chronic hepatitis C patients
- Hepatitis C viral infection